Letter by Govindarajan and Salgado regarding article, "Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) trial"

Circulation. 2012 Jan 24;125(3):e290; author reply e293-4. doi: 10.1161/CIRCULATIONAHA.111.053710.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / adverse effects*
  • Atrial Fibrillation / drug therapy*
  • Benzimidazoles / adverse effects*
  • Female
  • Hemorrhage / chemically induced*
  • Humans
  • Male
  • Warfarin / adverse effects*
  • beta-Alanine / analogs & derivatives*

Substances

  • Anticoagulants
  • Benzimidazoles
  • beta-Alanine
  • Warfarin